IXICO plc Notice of Results (5887Y)
10 May 2019 - 4:00PM
UK Regulatory
TIDMIXI
RNS Number : 5887Y
IXICO plc
10 May 2019
10 May 2019
IXICO plc
("IXICO" or the "Company")
Notice of Results
IXICO plc (AIM: IXI), the data analytics company delivering
insights in neuroscience, will announce its interim results for the
six months ended 31 March 2019 on Wednesday, 22 May 2019.
Giulio Cerroni, CEO and Grant Nash, CFO, will host a breakfast
briefing and call for analysts at 09:00 BST on the day of the
results at Cenkos Securities, 6-8 Tokenhouse Yard, London EC2R
7AS.
For further information please contact:
IXICO plc +44 (0) 20 3763 7498
Giulio Cerroni, Chief Executive Officer
Cenkos Securities PLC (Nominated adviser
and sole broker) +44 (0) 20 7397 8900
Giles Balleny / Max Gould (Corporate Finance)
Michael F Johnson / Russell Kerr (Sales)
Optimum Strategic Communications +44 (0) 203 950 9144
Mary Clark / Anne Marieke Ezendam / Supriya
Mathur
ixico@optimumcomms.com
About IXICO
IXICO is dedicated to delivering insights in neuroscience. Our
mission is to transform the progression of our biopharmaceutical
clients' neurological therapeutic pipelines through the application
of novel imaging and digital biomarkers.
IXICO's data analytics services are used by the global
biopharmaceutical industry to interpret data from brain scans and
digital biosensors to enable better trial design, site
qualification, patient selection and clinical outcomes. We provide
technology-enabled services across all phases of clinical
evaluation. Our integrated digital platform provides a scalable and
secure infrastructure for the capture and analysis of regulatory
compliant clinical data to enable clients to make rapid, better
informed decisions. IXICO is also collaborating with partners to
develop new analytical techniques and companion digital health
products targeted at improving patient outcomes.
More information is available on www.IXICO.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORDBGDUGBGBGCC
(END) Dow Jones Newswires
May 10, 2019 02:00 ET (06:00 GMT)
Ixico (LSE:IXI)
Historical Stock Chart
From Apr 2024 to May 2024
Ixico (LSE:IXI)
Historical Stock Chart
From May 2023 to May 2024
